Top Back to top

Abstract Topics

General topics

No. TOPIC
1 Haematopoietic stem cells
2 Stem cell mobilization, collection and engineering
3 Cellular Therapy
4 Gene Therapy
5 New drug- and cell-based immune therapies
6 Non-haematopoietic stem cells
7 Regenerative medicine

Transplant-specific topics

no. TOPIC
8 Stem cell source
9 Stem cell donor
10 Graft-versus-host disease – preclinical and animal models
11 Graft-versus-host disease – clinical
12 Infectious complications
13 Early complications / late effects & quality of life / fertility
14 Conditioning regimens
15 Minimal residual disease, tolerance, chimerism and immune reconstitution
16 Paediatric issues
17 Experimental stem cell transplantation

Disease-specific topics

no. TOPIC
18 Acute leukaemia
19 Aplastic anaemia
20 Autoimmune diseases
21 Chronic leukaemia and other myeloproliferative disorders
22 Granulocyte and osteoclast disorders
23 Haemoglobinopathy and inborn errors of metabolism
24 Immunodeficiency diseases and macrophages
25 Lymphoma
26 Multiple myeloma
27 Myelodysplastic syndromes
28 Solid tumours

Data Management Group

no. TOPIC
29 Data Management

Statistics

no. TOPIC
30 Statistics

Quality Management Group

no. TOPIC
31 Accreditation
32 Quality management
33 Regulatory issues
34 Sharing best quality practices

 

Care-specific topics

no. TOPIC
35 Care of the carer
36 Complementary therapies
37 Donor issues
38 Ethical issues
39 Impact of new therapies on patient care
40 Information and education
41 Management
42 Outpatient developments
43 Palliative care
44 Patient safety
45 Psycho-social issues
46 Protective care
47 Quality of life
48 Standards of care
49 Survivorship
50 Symptoms management
51 CAR-T or immune effector cells

 

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org